ZA931184B - The use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation - Google Patents

The use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation

Info

Publication number
ZA931184B
ZA931184B ZA931184A ZA931184A ZA931184B ZA 931184 B ZA931184 B ZA 931184B ZA 931184 A ZA931184 A ZA 931184A ZA 931184 A ZA931184 A ZA 931184A ZA 931184 B ZA931184 B ZA 931184B
Authority
ZA
South Africa
Prior art keywords
atoms
interruption
radical
treatment
blood circulation
Prior art date
Application number
ZA931184A
Other languages
English (en)
Inventor
Ismahan Okyayau-Baklouti
Maurice Mars
Michael Alfred Gregory
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA931184B publication Critical patent/ZA931184B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA931184A 1992-02-22 1993-02-19 The use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation ZA931184B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4205424 1992-02-22

Publications (1)

Publication Number Publication Date
ZA931184B true ZA931184B (en) 1993-09-16

Family

ID=6452327

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931184A ZA931184B (en) 1992-02-22 1993-02-19 The use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation

Country Status (13)

Country Link
EP (1) EP0557876B1 (fr)
JP (1) JP3193800B2 (fr)
KR (1) KR930017580A (fr)
AT (1) ATE146078T1 (fr)
AU (1) AU658979B2 (fr)
CA (1) CA2089959A1 (fr)
DE (1) DE59304710D1 (fr)
DK (1) DK0557876T3 (fr)
ES (1) ES2096115T3 (fr)
GR (1) GR3022183T3 (fr)
HU (1) HUT64472A (fr)
TW (1) TW288977B (fr)
ZA (1) ZA931184B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3792266B2 (ja) * 1994-06-16 2006-07-05 森精機興産株式会社 工作機械の熱変位補正方法及びその装置
DE19540798A1 (de) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US20070105878A1 (en) * 2005-10-03 2007-05-10 Andrew Reaume Purine formulations and methods for managing disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (fr) * 1974-01-22 1978-12-29 Wuelfing J A Fa
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
GB8621870D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Active compounds
EP0484785B1 (fr) * 1990-11-07 1996-05-22 Hoechst-Roussel Pharmaceuticals Incorporated Utilisation de xanthines pour la préparation de médicaments actifs comme inhibiteurs de la réplication des retrovirus humains

Also Published As

Publication number Publication date
CA2089959A1 (fr) 1993-08-23
JPH069634A (ja) 1994-01-18
DE59304710D1 (de) 1997-01-23
ES2096115T3 (es) 1997-03-01
AU3376193A (en) 1993-08-26
EP0557876B1 (fr) 1996-12-11
EP0557876A1 (fr) 1993-09-01
HUT64472A (en) 1994-01-28
JP3193800B2 (ja) 2001-07-30
KR930017580A (ko) 1993-09-20
ATE146078T1 (de) 1996-12-15
DK0557876T3 (da) 1997-05-26
AU658979B2 (en) 1995-05-04
HU9300476D0 (en) 1993-05-28
TW288977B (fr) 1996-10-21
GR3022183T3 (en) 1997-03-31

Similar Documents

Publication Publication Date Title
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
HU896769D0 (en) Fungicide compositions comprising azolylmethylcyclopentane-benzylidene-derivatives as active ingredient and process for preparation of the active ingredients
FI912998A (fi) Foerfarande foer framstaellning av aralifatiskt n-substituerade aminoalkanfosfinsyror.
SE9100342D0 (sv) Novel steroid esters
AU584274B2 (en) Process for the crosslinking of organopolysiloxanes
TW288977B (fr)
IL91913A0 (en) Fluorosubstituted benzene derivatives,processes for the preparation thereof and diagnostic compositions containing the same
EP0528164A3 (fr)
NZ236056A (en) Thiophene derivatives (optionally with a morpholino or piperazino substituent) and pharmaceutical compositions
OA09460A (fr) "Nouveaux dérivés d'oxazolo pyridines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
GR890300045T1 (en) Process for the preparation of 2,5-diamino-nitro-6-pyridine derivatives, their use in hair dyeing agents and these 2,5-diamino-6-nitro-pyridine derivatives
ZA918801B (en) Use of xanthinges for the preparation of a medicament effective for inhibiting the replication of human retroviruses
NZ216125A (en) Isoxazoles and pharmaceutical compositions
ES2096800T3 (es) Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos.
FI950259A0 (fi) Uudet, asykliset, amidiiniryhmiä sisältävät difosfonihappojohdannaiset, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet
SE7412163L (fr)
RU93004489A (ru) Лекарственное средство для профилактики и лечения повреждений мышц после прерывания кровообращения и способ лечения